Author

Nicolas Vigneron

InsermPrimary ORCID profile (0000-0002-0619-2993 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Nicolas VigneroniD1 paper · Centre National de la Recherche Scientifique

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

Céline VillenetiD· 2 shared Émilie Brotin· 2 shared Florence GiffardiD· 2 shared Guillaume Desmartin· 2 shared Jean‐Pascal MenebooiD· 2 shared Jordane DivouxiD· 2 shared Laurent PoulainiD· 2 shared Louis‐Bastien WeiswaldiD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Céline VillenetORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Predicting Head and Neck Squamous Cell Carcinoma outcomes using long-term Patient-Derived Tumor Organoids

Marion Perréard, Jordane Divoux, Félicie Perrin, Romane Florent, Lucie Lecouflet, Guillaume Desmartin, Lucie Thorel, Florence Giffard, Sarah Burton, Jade Richard, Jean‐Michel Grellard, Esther Lebreton, Émilie Brotin, Céline Villenet, Shéhérazade Sebda, , Louis‐Bastien Weiswald

This study uses patient-derived tumor organoids to predict HNSCC patient outcomes, finding strong associations between organoid responses to cisplatin and X-rays and clinical prognosis.

bioRxiv · Mar 24, 2026 · PreprintCancer Biology

Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response

Lucie Thorel, Énora Dolivet, Pierre‐Marie Morice, Romane Florent, Jordane Divoux, Marion Perréard, Lucie Lecouflet, Guillaume Desmartin, Chloé Marde Alagama, Florence Giffard, Alexandra Leconte, Justine Lequesne, Bénédicte Clarisse, Mélanie Briand, A Traoré, , Laurent Poulain

This study establishes patient-derived ovarian cancer organoids that mimic tumor characteristics and drug responses, showing potential for precision medicine.

Journal of Experimental & Clinical Cancer Research · Oct 7, 2025Peer-reviewedCancer Biology